Navitas Soars; AstraZeneca Invests $2 Billion in Summit; FICO Drops | Stock Movers
Community Score: 50% | 370 views | 2w
0 community ratings: null thumbs up, null thumbs down
Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Navitas Semiconductor (NVTS) shares are up, after the company said it was awarded the ALATTIS program by the US Army Research Laboratory to develop next-generation 10 kV silicon carbide power semiconductor technology for defense applications. - AstraZeneca (AZN) is investing $2 billion in US biotech Summit Therapeutics (SMMT) to collaborate on a promising new cancer medicine that could be combined with the British drugmaker’s other treatments. - Fair Issac, the credit score company known as FICO, slumps in premarket trading after Federal Housing Finance Agency Director Bill Pulte announced a move that makes it easier for lenders to adopt VantageScore. According to analysts, this will increase competition while pressuring FICO’s market share and pricing power. See omnystudio.com/listener (https://omnystudio.com/listener) for privacy information. Bloomberg journalists discuss today's biggest win
Tags: Business, Business News, Daily News, News, bloomberg, bloomberg news, business, finance, investing, investing news, markets, markets news, podcast, radio, stock, stock market, stocks, stocks podcast
More from Bloomberg Podcasts
- Follow the Money All the Way to Carney's Canada — Score: 50%
- Daybreak Weekend: US CPI, Europe Energy, RBA Decision | Bloomberg Daybreak: Europe Edition — Score: 50%
- Bloomberg Money: Credit Card Indicators and Golf's Changing Fanbase | Bloomberg Intelligence — Score: 50%
- We hear you! | Bloomberg Hot Pursuit! — Score: 50%
- Bloomberg Businessweek Weekend - August 7th, 2026 | Bloomberg Businessweek — Score: 50%
- Team Favorite: AI-Era Internet, Spaceport Investment, Bolivia’s Investability | Wall Street Week — Score: 50%